Development of Eating Disorders Symptoms Among Children
Eating Disorders Symptoms
About this trial
This is an interventional treatment trial for Eating Disorders Symptoms focused on measuring eating disorder, childhood obesity, family based treatment
Eligibility Criteria
Inclusion Criteria:
- Families who participated in "Active Maccabi
- Families who signed a consent form
- Families who attended 80% of the sessions
exclusion criteria:
- Families who don't fill in questionnaires at all stages of the research
- Families in which the parents refuse to sign a consent form
- Families in the control group who receive treatment in more than three sessions by a dietician in the community
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Other
Other
Retrospective Random Controlled Research
The Prospective study
In the controlled retrospective follow up, (not random) 44 families participated with their 81 children and siblings. The intervention group included 18 families who participated in the "Maccabi Active" program (obesity treatment) in the years 2012-2013 in the northern district, with their 24 children (18 overweight children and 6 siblings). The control group included 26 families with their 57 children (27 children who had been overweight or obese in the years 2012-2013 when they were 8-14 years old and their 30 siblings). These families did not take part in a family based treatment for their overweight child. The parameters were measured at one set point time. All participants from both the control and research groups were evaluated at the follow-up and the data collected at follow-up is being reported collectively for the Retrospective Controlled Research branch.
The Prospective study had only an intervention group (obesity treatment). Forty-two families took part in this study, with 78 children: 48 overweight children and 30 siblings . The parameters were measured in three different times. Before the program (time 1), at the end of the program (after 6 months - time 2) and 8 months after completing the program (time 3).